Covance has reimagined clinical research by developing a highly patient-centric approach to study design and execution. With the goal to reduce time onsite and to expedite patient screening and recruitment in mind, this approach blends a global patient support ecosystem with technology to allow patients to participate in clinical research from virtually anywhere.
Ongoing trials and studies currently starting for COVID-19 have begun implementing virtual and hybrid solutions more than ever. Join us as we discuss how these lessons learned can be applied to your dermatology clinical trials as we explore options to virtually capture investigator assessments, patient reported outcomes, measurements of lesions, full body mapping, photography and more.
This educational webinar will provide an overview of the mobile health technology space, highlighting other current relevant innovations applicable for dermatology virtual and hybrid trials. The discussion will be presented by Dr. Bola Oyegunwa and I-Shan Chiang.
Bola Oyegunwa, PhD, MBA, Vice President and Global Head of Hybrid and Virtual Trials, Covance
Dr. Bola Oyegunwa serves the biopharmaceutical industry as an experienced thought leader in developing and implementing innovative technology-enabled hybrid and virtual trial solutions. As a champion of reducing patient burden in clinical trials, he regularly engages with regulatory authorities across North America and Europe to remove regulatory barriers to the adoption of virtual clinical trials. Dr. Oyegunwa is an ex-strategy consultant and has held leadership roles in Corporate Strategy, Product Development and Innovation at leading CROs. He holds a PhD in Cellular Immunology & Microbiology, an MBA and MMB Professional Science Masters in Microbial Biotechnology, all from North Carolina State University.Message Presenter
I-Shan Chiang, MPH, MBA, Senior Director, Strategy & Planning, Clinical Development Services, Covance
Ms. Chiang has over 18 years of experience in clinical research and public health and currently supports the Inflammation, Infectious Disease, and General Medicine group at Covance, providing innovative strategies for dermatology clinical trials including atopic dermatitis, psoriasis, acne vulgaris, basal cell carcinomas and vitiligo. Before joining Covance, Ms. Chiang held different strategic and project management roles at a top CRO and the Centers for Disease Control and Prevention. Ms. Chiang received an MPH in Behavioral Sciences and Health Education from Emory University before obtaining her MBA in the Life Sciences at Johns Hopkins University.Message Presenter
Who Should Attend?
- Chief Medical Officer
- Chief Executive Officer
- Senior Medical Director
- Medical Director
- Clinical Development Director
- Research and Development Director
- Operational Director
- Senior Operational Director
- Clinical Director
- Senior Clinical Director
- Research Director
What You Will Learn
- Appreciate how mobile technologies can support COVID-19 issues in clinical trials
- Discuss Hybrid/Virtual trials in the clinical research space
- Become familiar with technological advances in mobile health platforms in dermatology clinical trials
- Understand services available for patients/sites
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. We generate more safety and efficacy data to support drug approvals than any other company, supporting our clients’ complete lifecycle management.
Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Visit us at www.covance.com.